Cronos Group Inc. (TSE:CRON) Given Average Rating of “Moderate Buy” by Brokerages

Shares of Cronos Group Inc. (TSE:CRONGet Rating) have been given an average recommendation of “Moderate Buy” by the nine brokerages that are covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is C$4.75.

A number of research firms recently weighed in on CRON. Jefferies Financial Group dropped their price target on Cronos Group from C$4.30 to C$3.90 in a report on Friday, August 12th. Barclays dropped their price target on Cronos Group from C$5.00 to C$3.50 and set a “na” rating for the company in a report on Friday, September 30th. Finally, MKM Partners dropped their price target on Cronos Group from C$10.00 to C$7.00 in a report on Tuesday, November 8th.

Cronos Group Trading Up 5.8 %

Shares of CRON opened at C$4.40 on Friday. The stock has a 50 day simple moving average of C$4.05 and a 200-day simple moving average of C$3.98. Cronos Group has a 1 year low of C$3.32 and a 1 year high of C$5.98. The stock has a market cap of C$1.67 billion and a PE ratio of -4.67. The company has a current ratio of 25.37, a quick ratio of 24.01 and a debt-to-equity ratio of 0.58.

About Cronos Group

(Get Rating)

Cronos Group Inc operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets.

Featured Articles

Analyst Recommendations for Cronos Group (TSE:CRON)

Receive News & Ratings for Cronos Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cronos Group and related companies with MarketBeat.com's FREE daily email newsletter.